ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Sunshine Biopharma, Inc. ?
1
Poor Management Efficiency with a low ROE of 0%
- The company has reported losses. Due to this company has reported negative ROE
2
With a growth in Net Sales of 11.64%, the company declared Very Positive results in Sep 25
- The company has declared positive results in Jan 70 after 2 consecutive negative quarters
- OPERATING CASH FLOW(Y) Highest at USD -7.12 MM
- OPERATING PROFIT(Q) Highest at USD -0.44 MM
- OPERATING PROFIT MARGIN(Q) Highest at -4.63 %
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -50.48%, its profits have fallen by -3.6%
4
Majority shareholders : FIIs
5
Below par performance in long term as well as near term
- Along with generating -50.48% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Sunshine Biopharma, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Sunshine Biopharma, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Sunshine Biopharma, Inc.
-55.26%
-1.34
64.56%
S&P 500
16.12%
0.77
19.29%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
107.29%
EBIT Growth (5y)
-227.58%
EBIT to Interest (avg)
-4.64
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.35
Sales to Capital Employed (avg)
1.23
Tax Ratio
5.58%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
7.89%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.23
EV to EBIT
0.75
EV to EBITDA
0.80
EV to Capital Employed
-0.24
EV to Sales
-0.10
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-18.08%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend12What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD -7.12 MM
OPERATING PROFIT(Q)
Highest at USD -0.44 MM
OPERATING PROFIT MARGIN(Q)
Highest at -4.63 %
PRE-TAX PROFIT(Q)
Highest at USD -0.47 MM
NET PROFIT(Q)
Highest at USD -0.33 MM
EPS(Q)
Highest at USD -0.19
-2What is not working for the Company
INVENTORY TURNOVER RATIO(HY)
Lowest at 2.12 times
DEBTORS TURNOVER RATIO(HY)
Lowest at 10.12 times
Here's what is working for Sunshine Biopharma, Inc.
Operating Cash Flow
Highest at USD -7.12 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Operating Profit
Highest at USD -0.44 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Operating Profit Margin
Highest at -4.63 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at USD -0.47 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Pre-Tax Profit
At USD -0.47 MM has Grown at 52.51%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD -0.33 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
Net Profit
At USD -0.33 MM has Grown at 72.52%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD -0.19
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Here's what is not working for Sunshine Biopharma, Inc.
Inventory Turnover Ratio
Lowest at 2.12 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Debtors Turnover Ratio
Lowest at 10.12 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
